The biological definition of AD effectively deconstructs a disease [26] into a special form of “brain amyloidosis” (amyloid and tau), which determines a risk of future dementia, but its therapies do not cure dementia (and it is debatable whether they delay it) [103,104,105,267]. The gene discussed is MAPT; the disease is amyloidosis.